Abstract
Sustainability, affordability, and equity of corporate drug donations: the case of Malarone
Shretta, R.
Brugha, R.
Robb, A.
Snow, R. W.
Lancet. 2000; 3551718-20
Permanent descriptor
https://doi.org/10.1016/s0140-6736(00)02251-0No abstract available
